Cartesian Therapeutics Inc. (RNAC) — Financial Flexibility Index
Cartesian Therapeutics Inc. (RNAC) has a Financial Flexibility Index of -0.05x as of March 2026. Free cash flow of $-22.11 Million (operating CF $-22.14 Million minus capex $27.00K) represents 0% of total liabilities ($436.51 Million). Check RNAC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cartesian Therapeutics Inc. Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Cartesian Therapeutics Inc. across 12 annual periods. For the full cash flow conversion analysis, see Cartesian Therapeutics Inc. (RNAC) cash flow conversion.
Annual Financial Flexibility Index for Cartesian Therapeutics Inc. (2014–2025)
Year-by-year free cash flow to debt coverage for Cartesian Therapeutics Inc.. Explore Cartesian Therapeutics Inc. (RNAC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.16x | $-68.49 Million | $-73.94 Million | $422.65 Million | ▼ -391.0% |
| 2024 | -0.03x | $-14.58 Million | $-23.67 Million | $441.82 Million | ▲ +51.7% |
| 2023 | -0.07x | $-50.95 Million | $-51.16 Million | $745.23 Million | ▲ +83.8% |
| 2022 | -0.42x | $-30.43 Million | $-31.63 Million | $72.06 Million | ▲ +2.2% |
| 2021 | -0.43x | $-59.30 Million | $-60.38 Million | $137.36 Million | ▼ -321.8% |
| 2020 | 0.19x | $35.70 Million | $34.88 Million | $183.44 Million | ▲ +134.5% |
| 2019 | -0.56x | $-51.39 Million | $-51.44 Million | $91.17 Million | ▲ +51.7% |
| 2018 | -1.17x | $-58.28 Million | $-59.16 Million | $49.90 Million | ▼ -12.2% |
| 2017 | -1.04x | $-51.30 Million | $-52.04 Million | $49.29 Million | ▼ -87.2% |
| 2016 | -0.56x | $-19.10 Million | $-19.68 Million | $34.34 Million | ▼ -315.9% |
| 2015 | -0.13x | $-21.30 Million | $-22.46 Million | $159.32 Million | ▼ -18.0% |
| 2014 | -0.11x | $-12.46 Million | $-12.69 Million | $109.98 Million | — |